Balyasny Asset Management LLC Edwards Lifesciences Corp Call Options Transaction History

Balyasny Asset Management LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $725,400 - $955,600	10,000 New	10,000 $955,000
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $29.3 Million - $39.5 Million	422,500 New	422,500 $29.3 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $15.7 Million - $23.3 Million	182,000 New	182,000 $17.3 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $751,243 - $896,075	-7,300 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $1.9 Million - $2.38 Million	-22,700 Reduced 75.67%	7,300 $756,000
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $1.85 Million - $2.26 Million	30,000 New	30,000 $6.6 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $5.29 Million - $6.49 Million	-114,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $5.21 Million - $6.62 Million	114,000 New	114,000 $17 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.